These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 22976499)
1. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Di Giuda D; Camardese G; Bentivoglio AR; Cocciolillo F; Guidubaldi A; Pucci L; Bruno I; Janiri L; Giordano A; Fasano A Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1937-48. PubMed ID: 22976499 [TBL] [Abstract][Full Text] [Related]
2. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454 [TBL] [Abstract][Full Text] [Related]
3. Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Erro R; Pappatà S; Barone P; Pellecchia MT Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):636-7. PubMed ID: 23224741 [No Abstract] [Full Text] [Related]
4. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease. Kaasinen V; Kinos M; Joutsa J; Seppänen M; Noponen T Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1931-7. PubMed ID: 24867256 [TBL] [Abstract][Full Text] [Related]
5. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. Di Giuda D; Camardese G; Cocciolillo F; Fasano A Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):638-9. PubMed ID: 23224742 [No Abstract] [Full Text] [Related]
7. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis. Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156 [TBL] [Abstract][Full Text] [Related]
8. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT. Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099 [TBL] [Abstract][Full Text] [Related]
10. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298 [TBL] [Abstract][Full Text] [Related]
11. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365 [TBL] [Abstract][Full Text] [Related]
12. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings. Gigante AF; Defazio G; Niccoli Asabella A; Superbo M; Ferrari C; Liuzzi D; Iliceto G; Livrea P; Rubini G Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996 [TBL] [Abstract][Full Text] [Related]
13. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712 [TBL] [Abstract][Full Text] [Related]
14. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results. Jauković L; Ilić TV; Dopudja M; Ajdinović B Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic dysfunction in the left putamen of patients with major depressive disorder. D'Onofrio AM; Pizzuto DA; Batir R; Perrone E; Cocciolillo F; Cavallo F; Kotzalidis GD; Simonetti A; d'Andrea G; Pettorruso M; Sani G; Di Giuda D; Camardese G J Affect Disord; 2024 Jul; 357():107-115. PubMed ID: 38636713 [TBL] [Abstract][Full Text] [Related]
16. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575 [TBL] [Abstract][Full Text] [Related]
18. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease. Song IU; Chung YA; Oh JK; Chung SW Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629 [TBL] [Abstract][Full Text] [Related]
19. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424 [TBL] [Abstract][Full Text] [Related]